Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan

Clinical trial NCT02042014 · COMPLETED

Trial details

NCT number: NCT02042014
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Pulmonary Arterial Hypertension

Start date: 2014-01-22
Primary completion: 2016-10-17
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.